In a new periodic feature, IBO highlights major funding announcements and initiatives that indicate opportunities for instrument and laboratory product makers. Samsung announced in May the formation of the Samsung Future Technology Promotion Foundation, which will invest KRW 1.5 trillion ($900 million = KRW 1.11 =$1) over 10 years in R&D. The Foundation plans to […]

Madison, WI 7/24/13; Madison, WI 7/30/13—Cellular Dynamics International, a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, has completed its IPO (see IBO 6/15/13, 7/15/13). The company offered 3,846,000 shares of common stock at a price of $12 per share, raising approximately $43 million after deducting underwriting discounts and […]

Company Announcements Takashi Nishijima, director and senior vice president of the Industrial Automation Platform Business, was named representative director and president of Yokogawa Electric, effective April 1. SICK acquired in April Ação Solucão, its Brazilian distributor. Ação Solucão has more than 30 employees. SICK’s 2012 revenues rose 7.6% to €971.3 million ($1,245 million) (see page […]

Company Announcements GE Healthcare Life Sciences revenue was flat in the first quarter, according to GE’s conference call. FLIR Systems named Andrew C. Teich, president of Commercial Systems, president and CEO in May, replacing Earl Lewis, who remains chairman. QIAGEN first quarter revenues grew 2.4%, 1% organically, to $303.6 million (see IBO 4/30/13). AmniSure (see […]

First quarter revenues for the IBO Lab Equipment/Consumables Index grew 0.9%, 1.8% excluding currency, to $4,125 million. Adjusted operating profit declined 1.7% to $730 million. Based on continuing operations, operating margin for the Index contracted 70 basis points to 18.3% of sales. Kewaunee Scientific fiscal fourth quarter sales ending April 30 grew 9.7% to $31.8 […]

With the addition of Oxford Instruments and details of Shimadzu’s financial results, first quarter IBO Laboratory Sales Index revenues are now estimated to have grown 0.6%, 1.9% excluding currency, to $5,905 million (see IBO 5/15/13). Operating profit declined 2.9% to $1,215 million, and operating margin contracted 60 basis points to 18.1% of sales. For the […]

Fears over higher US interest rates and a reduction in the Federal Reserve’s quantitative easing measures sent equity markets lower in June. Ironically, markets erased some of the earlier losses as first quarter US GDP was revised down to 1.8% growth from 2.4%. The weaker-than-expected economic growth appeased investors’ concerns that the Federal Reserve’s bond […]